Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.1.111 extracted from

  • Ashida, H.; Miyake, A.; Kiyohara, M.; Wada, J.; Yoshida, E.; Kumagai, H.; Katayama, T.; Yamamoto, K.
    Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates (2009), Glycobiology, 19, 1010-1017.
    View publication on PubMed
Search for more literature for 3.2.1.111

Cloned(Commentary)

Cloned (Comment) Organism
expression in Escherichia coli. Introduction of afcB gene into the Bacterioides longum 105-A strain, which has no intrinsic alpha-L-fucosidase. The transformant is able to utilize 3-fucosyllactose and lacto-N-fucopentaose II as the sole carbon source Bifidobacterium bifidum

Protein Variants

Protein Variants Comment Organism
additional information introduction of afcB gene into the Bacterioides longum 105-A strain, which has no intrinsic alpha-L-fucosidase. The transformant is able to utilize 3-fucosyllactose and lacto-N-fucopentaose II as the sole carbon source Bifidobacterium bifidum

Inhibitors

Inhibitors Comment Organism Structure
Co2+ 40% residual activity Bifidobacterium bifidum
Cu2+ complete inactiviation Bifidobacterium bifidum

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
160000
-
 2 * 160000, SDS-PAGE Bifidobacterium bifidum
350000
-
 gel filtration Bifidobacterium bifidum

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Bifidobacterium bifidum Bifidobacteria are predominant bacteria present in the intestines of breast-fed infants and offer important health benefits for the host. alpha-L-Fucosidase AfcB play essential roles in degrading alpha1,3/4-fucosylated milk oligosaccharides, respectively, and also glycoconjugates, in the gastrointestinal tracts ?
-
 ?

Organism

Organism UniProt Comment Textmining
Bifidobacterium bifidum
-
 JCM1254
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
L-Fuc-alpha-(1->2)-D-Gal-beta-(1->3)-[L-Fuc-alpha-(1->4)]-GlcNAc + H2O i.e. Lewis b tetrasaccharide, 14% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose + L-Fuc-alpha-(1->2)-D-Gal-beta-(1->3)-D-GlcNAc
-
 ?
L-Fuc-alpha-(1->2)-D-Gal-beta-(1->4)-[L-Fuc-alpha-(1->3)]-D-GlcNAc + H2O i.e. Lewis y tetrasaccharide, 128% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose + L-Fuc-alpha-(1->2)-D-Gal-beta-(1->4)-D-GlcNAc
-
 ?
L-Fuc-alpha-(1->3)-[D-Gal-beta-(1->4)]-D-Glc + H2O i.e. 3-fucosyllactose Bifidobacterium bifidum L-fucose + D-Gal-beta-(1->4)-D-Glc
-
 ?
L-Fuc-alpha-(1->3)-[D-Gal-beta-(1->4)]-D-GlcNAc + H2O i.e. Lewis a trisaccharide, 160% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose + D-Gal-beta-(1->4)-D-GlcNAc
-
 ?
L-Fuc-alpha-(1->3)-[D-Gal-beta-(1->4)]-D-GlcNAc-beta-(1->3)-D-Gal-beta-(1->4)-D-Glc + H2O i.e. lacto-N-fucopentaose III, 159% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose + D-Gal-beta-(1->4)-D-GlcNAc-beta-(1->3)-D-Gal-beta-(1->4)-D-Glc
-
 ?
L-Fuc-alpha-(1->4)-D-Gal-beta-(1->3)-D-GlcNAc-beta-(1->3)-D-Gal-beta-(1->4)-D-Glc + H2O i.e. lacto-N-fucopentaose II, 186% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose +
-
 ?
L-Fuc-alpha-(1->4)-[D-Gal-beta-(1->3)]-D-GlcNAc + H2O i.e. Lewis a trisaccharide, 166% of the activity with 3-fucosyllactose Bifidobacterium bifidum L-fucose + D-Gal-beta-(1->3)-D-GlcNAc
-
 ?
additional information Bifidobacteria are predominant bacteria present in the intestines of breast-fed infants and offer important health benefits for the host. alpha-L-Fucosidase AfcB play essential roles in degrading alpha1,3/4-fucosylated milk oligosaccharides, respectively, and also glycoconjugates, in the gastrointestinal tracts Bifidobacterium bifidum ?
-
 ?
additional information enzyme specifically releases alpha-1,3- and alpha-1,4-linked fucosyl residues from 3-fucosyllactose, various Lewis blood group substances, and lacto-N-fucopentaose II and III. The enzyme does not act on glycoconjugates containing alpha-1,2-fucosyl residue or on synthetic alpha-fucoside, i.e. p-nitrophenyl-alpha-L-fucoside Bifidobacterium bifidum ?
-
 ?

Subunits

Subunits Comment Organism
dimer 2 * 160000, SDS-PAGE Bifidobacterium bifidum

Synonyms

Synonyms Comment Organism
AfcB
-
 Bifidobacterium bifidum

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
45
-
-
 Bifidobacterium bifidum

Temperature Stability [°C]

Temperature Stability Minimum [°C] Temperature Stability Maximum [°C] Comment Organism
50
-
 stable below, pH 6.0 Bifidobacterium bifidum

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
5.5 6
-
 Bifidobacterium bifidum

pH Stability

pH Stability pH Stability Maximum Comment Organism
3.5 8 stable Bifidobacterium bifidum

General Information

General Information Comment Organism
physiological function Bifidobacteria are predominant bacteria present in the intestines of breast-fed infants and offer important health benefits for the host. alpha-L-Fucosidase AfcB play essential roles in degrading alpha1,3/4-fucosylated milk oligosaccharides, respectively, and also glycoconjugates, in the gastrointestinal tracts Bifidobacterium bifidum

kcat/KM [mM/s]

kcat/KM Value [1/mMs-1] kcat/KM Value Maximum [1/mMs-1] Substrate Comment Organism Structure
0.46
-
 L-Fuc-alpha-(1->3)-[D-Gal-beta-(1->4)]-D-Glc pH 6.0, 37°C Bifidobacterium bifidum